Biotech Values

[DewDiligence]

Monthly Branded/Generic US Lovenox Scripts

I’ve converted Rocky’s weekly script numbers to average weekly
figures for each month, which gives a better indication of the trend.
See #msg-68906536 for the same data aggregated by quarter.

For the past several months, NVS/MNTA’s generic Lovenox has had
a retail market share of 86-87%; however, SNY’s authorized generic,
which was launched in October, is not yet captured in these data.

 
                           Script 
         Avg Wkly Scripts  Share of 
 Month   Branded  Generic  Generic 
 1011      7,941   50,435   86.4%

0911 7,636 48,930 86.5%
0811 7,592 48,767 86.5%
0711 7,832 48,854 86.2%
0611 8,069 50,243 86.2%
0511 8,534 52,765 86.1%
0411 9,213 53,041 85.2%
0311 12,767 48,278 79.1%
0211 22,769 35,025 60.6%
0111 25,279 31,124 55.2%
1210 25,767 29,332 53.2%
1110 28,082 28,081 50.0%
1010 30,398 26,412 46.5%
0910 31,319 23,304 42.7%
0810 37,611 16,876 31.0%